Research programme: hormone-sensitive lipase inhibitors - Novo Nordisk

Drug Profile

Research programme: hormone-sensitive lipase inhibitors - Novo Nordisk

Alternative Names: 76-0079; Hormone-sensitive lipase inhibitors research programme - Novo Nordisk; HSL inhibitors - Novo Nordisk

Latest Information Update: 24 Feb 2011

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Novo Nordisk
  • Class Boronic acids; Triazoles
  • Mechanism of Action Sterol esterase inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • No development reported Diabetes mellitus

Most Recent Events

  • 07 Sep 2004 Preclinical trials in Diabetes mellitus in Denmark (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top